1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AVADEL PHARMACEUTICALS PLC - ADR

Avadel Pharmaceuticals plc - ADR

XNAS: AVDL

Momentum Trap
Download real time

8.57 -0.10 (-1.15%)

55.11% Fall from 52W High

910.6K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
11W
2O
1T
828.1

Market Cap

Below industry Median
-17

PE TTM

Negative PE TTM
-0.2

PEG TTM

PEG TTM is negative
11.1

Price to Book

High in industry
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Avadel Pharmaceuticals plc - ADR

The latest disclosure was made by Jerad G. Seurer in Avadel Pharmaceuticals plc - ADR where a trade of 14,700 Ordinary Shares done was reported to US exchanges on March 5, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jerad G. Seurer Gen. Counsel & Corp. Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 14,700 23,495 (0%) 0% 0 Ordinary Shares
Jerad G. Seurer Gen. Counsel & Corp. Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 84,000 84,000 - - Stock Option (Right to Buy)
Thomas S. Mchugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 72,000 72,000 - - Stock Option (Right to Buy)
Thomas S. Mchugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 12,600 100,400 (0%) 0% 0 Ordinary Shares
Gregory J. Divis Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 52,000 211,100 (0%) 0% 0 Ordinary Shares
Gregory J. Divis Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 310,000 310,000 - - Stock Option (Right to Buy)
Linda S. Palczuk Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Jan 2025 25,000 0 - - Stock Option (Right to Buy)
Linda S. Palczuk Director Purchase of securities on an exchange or from another person at price $ 7.93 per share. 21 Jan 2025 5,000 67,900 (0%) 0% 7.9 39,640 Ordinary Shares
Eric J. Ende Director Purchase of securities on an exchange or from another person at price $ 7.84 per share. 13 Jan 2025 30,000 208,900 (0%) 0% 7.8 235,218 Ordinary Shares
Peter Thornton Director Purchase of securities on an exchange or from another person at price $ 8.04 per share. 13 Jan 2025 10,000 104,055 (0%) 0% 8.0 80,450 Ordinary Shares
Palczuk Linda S. Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Dec 2024 3,500 62,900 (0%) 0% 0 Ordinary Shares
Palczuk Linda S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 25,000 25,000 - - Stock Option (Right to Buy)
Thomas S. Mchugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 10.44 per share. 13 Dec 2024 2,300 87,800 (0%) 0% 10.4 24,019 Ordinary Shares
Thomas S. Mchugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 10.49 per share. 11 Dec 2024 5,000 85,500 (0%) 0% 10.5 52,433 Ordinary Shares
Geoffrey Glass Director Purchase of securities on an exchange or from another person at price $ 9.80 per share. 10 Dec 2024 10,204 75,904 (0%) 0% 9.8 99,999 Ordinary Shares
Geoffrey Glass Director Purchase of securities on an exchange or from another person at price $ 9.89 per share. 10 Dec 2024 10,075 69,075 (0%) 0% 9.9 99,642 Ordinary Shares
Linda S. Palczuk Director Purchase of securities on an exchange or from another person at price $ 10.19 per share. 06 Dec 2024 3,000 66,400 (0%) 0% 10.2 30,568 Ordinary Shares
Gregory J. Divis Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 9.82 per share. 06 Dec 2024 402 10,000 (0%) 0% 9.8 3,948 Ordinary Shares
Gregory J. Divis Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 9.98 per share. 06 Dec 2024 9,598 9,598 (0%) 0% 10.0 95,759 Ordinary Shares
Linda S. Palczuk Director Gift of securities by or to the insider at price $ 0.00 per share. 15 Sep 2024 11,000 0 - - Stock Option (Right to Buy)
Geoffrey Glass Director Gift of securities by or to the insider at price $ 0.00 per share. 13 Sep 2024 11,000 0 - - Stock Option (Right to Buy)
Naseem S Amin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 (0%) 0% 0 Ordinary Shares
Mark A. Mccamish Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 (0%) 0% 0 Ordinary Shares
Mark A. Mccamish Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Peter Thornton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Peter Thornton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 94,055 (0%) 0% 0 Ordinary Shares
Naseem S Amin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Eric J. Ende Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Eric J. Ende Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 178,900 (0%) 0% 0 Ordinary Shares
Geoffrey Glass Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 (0%) 0% 0 Ordinary Shares
Geoffrey Glass Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Linda S. Palczuk Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 63,400 (0%) 0% 0 Ordinary Shares
Linda S. Palczuk Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 11,000 11,000 - - Stock Option (Right to Buy)
Naseem Amin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2024 49,500 49,500 - - Stock Option (Right to Buy)
Gregory J. Divis Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 600,000 600,000 - - Stock Option (Right to Buy)
Richard Kim Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 147,000 147,000 - - Stock Option (Right to Buy)
Thomas S. Mchugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 157,500 157,500 - - Stock Option (Right to Buy)
Thomas S. Mchugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 14.50 per share. 16 Jan 2024 2,000 80,500 (0%) 0% 14.5 29,000 ADSs
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters